Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
European Heart Journal|July 5, 2011
Myeloperoxidase deficiency preserves vasomotor function in humansTanja K Rudolph, Sabine Wipper, Beate Reiter, et al.
Circulation|April 12, 2006
Heparins increase endothelial nitric oxide bioavailability by liberating vessel-immobilized myeloperoxidaseStephan Baldus, Volker Rudolph, Mika Roiss, et al.
Blood|October 29, 2010
Myeloperoxidase attracts neutrophils by physical forcesAnna Klinke, Claudia Nussbaum, Lukas Kubala, et al.
Oncotarget|May 2, 2019
Clinical validation of the tempus xT next-generation targeted oncology sequencing assayNike Beaubier, Robert Tell, Denise Lau, et al.
Plos One|May 8, 2015
High Affinity Antibodies against Influenza Characterize the Plasmablast Response in SLE Patients After VaccinationKaval Kaur, Nai-Ying Zheng, Kenneth Smith, et al.
Nature Biotechnology|October 2, 2019
Integrated genomic profiling expands clinical options for patients with cancerNike Beaubier, Martin Bontrager, Robert Huether, et al.
Circulation|November 16, 2011
Pathogenic cycle between the endogenous nitric oxide synthase inhibitor asymmetrical dimethylarginine and the leukocyte-derived hemoprotein myeloperoxidaseEike-Christin von Leitner, Anna Klinke, Dorothee Atzler, et al.
JCI Insight|June 8, 2018
Myeloperoxidase aggravates pulmonary arterial hypertension by activation of vascular Rho-kinaseAnna Klinke, Eva Berghausen, Kai Friedrichs, et al.
Oncotarget|June 15, 2018
Clinical validation of the Tempus xO assayNike Beaubier, Robert Tell, Robert Huether, et al.
Circulation Research|April 14, 2017
Myeloperoxidase Mediates Postischemic Arrhythmogenic Ventricular RemodelingMartin Mollenhauer, Kai Friedrichs, Max Lange, et al.
Pageof 4